Cargando…

Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity

Inositol pyrophosphates have emerged as important regulators of many critical cellular processes from vesicle trafficking and cytoskeletal rearrangement to telomere length regulation and apoptosis. We have previously demonstrated that 5-di-phosphoinositol pentakisphosphate, IP(7), is at a high level...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajasekaran, Subu Surendran, Illies, Christopher, Shears, Stephen B., Wang, Huanchen, Ayala, Thais S., Martins, Joilson O., Daré, Elisabetta, Berggren, Per-Olof, Barker, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765549/
https://www.ncbi.nlm.nih.gov/pubmed/29042286
http://dx.doi.org/10.1016/j.cellsig.2017.10.008
_version_ 1783292252795174912
author Rajasekaran, Subu Surendran
Illies, Christopher
Shears, Stephen B.
Wang, Huanchen
Ayala, Thais S.
Martins, Joilson O.
Daré, Elisabetta
Berggren, Per-Olof
Barker, Christopher J.
author_facet Rajasekaran, Subu Surendran
Illies, Christopher
Shears, Stephen B.
Wang, Huanchen
Ayala, Thais S.
Martins, Joilson O.
Daré, Elisabetta
Berggren, Per-Olof
Barker, Christopher J.
author_sort Rajasekaran, Subu Surendran
collection PubMed
description Inositol pyrophosphates have emerged as important regulators of many critical cellular processes from vesicle trafficking and cytoskeletal rearrangement to telomere length regulation and apoptosis. We have previously demonstrated that 5-di-phosphoinositol pentakisphosphate, IP(7), is at a high level in pancreatic β-cells and is important for insulin exocytosis. To better understand IP(7) regulation in β-cells, we used an insulin secreting cell line, HIT-T15, to screen a number of different pharmacological inhibitors of inositide metabolism for their impact on cellular IP(7). Although the inhibitors have diverse targets, they all perturbed IP(7) levels. This made us suspicious that indirect, off-target effects of the inhibitors could be involved. It is known that IP(7) levels are decreased by metabolic poisons. The fact that the inositol hexakisphosphate kinases (IP6Ks) have a high K(m) for ATP makes IP(7) synthesis potentially vulnerable to ATP depletion. Furthermore, many kinase inhibitors are targeted to the ATP binding site of kinases, but given the similarity of such sites, high specificity is difficult to achieve. Here, we show that IP(7) concentrations in HIT-T15 cells were reduced by inhibitors of PI3K (wortmannin, LY294002), PI4K (Phenylarsine Oxide, PAO), PLC (U73122) and the insulin receptor (HNMPA). Each of these inhibitors also decreased the ATP/ADP ratio. Thus reagents that compromise energy metabolism reduce IP(7) indirectly. Additionally, PAO, U73122 and LY294002 also directly inhibited the activity of purified IP6K. These data are of particular concern for those studying signal transduction in pancreatic β-cells, but also highlight the fact that employment of these inhibitors could have erroneously suggested the involvement of key signal transduction pathways in various cellular processes. Conversely, IP(7)’s role in cellular signal transduction is likely to have been underestimated.
format Online
Article
Text
id pubmed-5765549
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Science Ltd
record_format MEDLINE/PubMed
spelling pubmed-57655492018-01-18 Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity Rajasekaran, Subu Surendran Illies, Christopher Shears, Stephen B. Wang, Huanchen Ayala, Thais S. Martins, Joilson O. Daré, Elisabetta Berggren, Per-Olof Barker, Christopher J. Cell Signal Article Inositol pyrophosphates have emerged as important regulators of many critical cellular processes from vesicle trafficking and cytoskeletal rearrangement to telomere length regulation and apoptosis. We have previously demonstrated that 5-di-phosphoinositol pentakisphosphate, IP(7), is at a high level in pancreatic β-cells and is important for insulin exocytosis. To better understand IP(7) regulation in β-cells, we used an insulin secreting cell line, HIT-T15, to screen a number of different pharmacological inhibitors of inositide metabolism for their impact on cellular IP(7). Although the inhibitors have diverse targets, they all perturbed IP(7) levels. This made us suspicious that indirect, off-target effects of the inhibitors could be involved. It is known that IP(7) levels are decreased by metabolic poisons. The fact that the inositol hexakisphosphate kinases (IP6Ks) have a high K(m) for ATP makes IP(7) synthesis potentially vulnerable to ATP depletion. Furthermore, many kinase inhibitors are targeted to the ATP binding site of kinases, but given the similarity of such sites, high specificity is difficult to achieve. Here, we show that IP(7) concentrations in HIT-T15 cells were reduced by inhibitors of PI3K (wortmannin, LY294002), PI4K (Phenylarsine Oxide, PAO), PLC (U73122) and the insulin receptor (HNMPA). Each of these inhibitors also decreased the ATP/ADP ratio. Thus reagents that compromise energy metabolism reduce IP(7) indirectly. Additionally, PAO, U73122 and LY294002 also directly inhibited the activity of purified IP6K. These data are of particular concern for those studying signal transduction in pancreatic β-cells, but also highlight the fact that employment of these inhibitors could have erroneously suggested the involvement of key signal transduction pathways in various cellular processes. Conversely, IP(7)’s role in cellular signal transduction is likely to have been underestimated. Elsevier Science Ltd 2018-01 /pmc/articles/PMC5765549/ /pubmed/29042286 http://dx.doi.org/10.1016/j.cellsig.2017.10.008 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Rajasekaran, Subu Surendran
Illies, Christopher
Shears, Stephen B.
Wang, Huanchen
Ayala, Thais S.
Martins, Joilson O.
Daré, Elisabetta
Berggren, Per-Olof
Barker, Christopher J.
Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity
title Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity
title_full Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity
title_fullStr Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity
title_full_unstemmed Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity
title_short Protein kinase- and lipase inhibitors of inositide metabolism deplete IP(7) indirectly in pancreatic β-cells: Off-target effects on cellular bioenergetics and direct effects on IP6K activity
title_sort protein kinase- and lipase inhibitors of inositide metabolism deplete ip(7) indirectly in pancreatic β-cells: off-target effects on cellular bioenergetics and direct effects on ip6k activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765549/
https://www.ncbi.nlm.nih.gov/pubmed/29042286
http://dx.doi.org/10.1016/j.cellsig.2017.10.008
work_keys_str_mv AT rajasekaransubusurendran proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT illieschristopher proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT shearsstephenb proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT wanghuanchen proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT ayalathaiss proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT martinsjoilsono proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT dareelisabetta proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT berggrenperolof proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity
AT barkerchristopherj proteinkinaseandlipaseinhibitorsofinositidemetabolismdepleteip7indirectlyinpancreaticbcellsofftargeteffectsoncellularbioenergeticsanddirecteffectsonip6kactivity